Drugmaker AstraZeneca has agreed to pay $520 million to settle federal investigations into marketing practices for its schizophrenia drug Seroquel. This makes AstraZeneca the 4th big drug company in the last three years to admit to federal charges of illegal marketing of antipsychotic drugs. The company was accused of misleading doctors and patients by spotlighting favourable research, while failing to adequately disclose studies showing that Seroquel increases the risk of diabetes.
Source: New York Times April 26, 2010; The United States Department of Justice April 27, 2010.
